Guidelines for the management of the acute painful crisis in sickle cell disease

Br J Haematol. 2003 Mar;120(5):744-52. doi: 10.1046/j.1365-2141.2003.04193.x.

Authors

David C Rees¹, Ade D Olujohungbe, Norman E Parker, Adrian D Stephens, Paul Telfer, Josh Wright; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party

Affiliation

¹ Department of Haematology, King's College Hospital, Denmark Hill, London, UK. david.rees@kcl.ac.uk

PMID: 12614204
DOI: 10.1046/j.1365-2141.2003.04193.x

No abstract available

Publication types

Guideline
Practice Guideline

MeSH terms

Adult
Analgesics, Opioid / therapeutic use
Anemia, Sickle Cell / complications
Anemia, Sickle Cell / nursing
Anemia, Sickle Cell / therapy*
Anti-Bacterial Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Behavior Therapy / methods
Blood Transfusion
Child
Female
Fluid Therapy / methods
Hospitalization
Humans
Narcotics / therapeutic use
Oxygen / therapeutic use
Pain / etiology
Pain / nursing
Pain / prevention & control*
Physical Therapy Modalities
Pregnancy
Pregnancy Complications, Hematologic / therapy
Psychotherapy / methods
Renal Insufficiency / therapy

Substances

Analgesics, Opioid
Anti-Bacterial Agents
Anti-Inflammatory Agents, Non-Steroidal
Narcotics
Oxygen